Loading clinical trials...
Loading clinical trials...
APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
Conditions
Interventions
LAU-7b
Placebo oral capsule
Locations
40
United States
Long Beach Memorial Medical Center
Long Beach, California, United States
Children's Hospital Los Angeles
Los Angeles, California, United States
UC Davis Medical Center, Division of Pulmonary & Critical Care Medicine
Sacramento, California, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
Division of pulmonary, critical care and sleep medicine, University of Florida
Gainesville, Florida, United States
Memorial Healthcare System, Joe DiMaggio Children's Hospital Cystic Fibrosis & Pulmonary Center
Hollywood, Florida, United States
Start Date
November 5, 2018
Primary Completion Date
September 15, 2021
Completion Date
September 15, 2021
Last Updated
October 9, 2024
NCT02417740
NCT06616857
NCT07108153
NCT02740868
NCT07274631
NCT07303621
Lead Sponsor
Laurent Pharmaceuticals Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions